Onsdag 25 Februari | 12:30:15 Europe / Stockholm
Svenska | English

Carlsquare

Bifogade filer

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Research update Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
2026-02-25 11:07:00

Carlsquare Equity Research has published a research update following the Q4 2025 report.

Read the update here.

About Carlsquare

Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more

Contacts

MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
 
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59

Attachments

Research update Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden